CHOP and COG Will Validate New Tool to Measure NF1-Related Progressive Vision Loss
Published on
CHOP researchers will use optical coherence tomography (OCT) to measure vision changes associated with NF1-related optic pathway gliomas.
Neurofibromatosis Program News and Updates
1 - 4 of 4
Study Demonstrates Efficacy of New Treatment for Neurofibromatosis Type 1-Related Tumors
Published on
A Phase 2 clinical trial involving CHOP and the Neurofibromatosis Clinical Trials Consortium showed cabozantinib reduced tumor volume and pain.
CHOP Participates in a Multi-institutional Clinical Trial Leading to First-Ever Therapy for Neurofibromatosis Type 1
Published on
New therapy shrinks tumors associated with NF1 and improves quality of life.
Streamlining Care for Patients with Neurofibromatosis Type 1
Published on
The Neurofibromatosis Multidisciplinary Clinic allows patients with NF1 to see three or more specialists in one day, allowing for a seamless flow of appointments from morning until afternoon.